Effect of NanoChitosan Impregnated Calcium Hydroxide as an Intracanal Medication on Postoperative… (NCT06253247) | Clinical Trial Compass
UnknownNot Applicable
Effect of NanoChitosan Impregnated Calcium Hydroxide as an Intracanal Medication on Postoperative Pain Intensity and Bacterial Load Reduction
45 participantsStarted 2024-04
Plain-language summary
This research will study the effect of NanoChitosan impregnated Calcium Hydroxide versus Calcium Hydroxide as an intracanal medication on postoperative pain intensity measured using numerical rating scale (NRS) and bacterial load reduction determined by bacterial counting using agar culture technique after root canal preparation (CFU/ml) in necrotic teeth.
Who can participate
Age range25 Years – 45 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age between 25-45 years old.
✓. Males or females.
✓. Healthy patients who are categorized as I or II according to The American Society of Anesthesiologists. (ASA I or II)
✓. Patients' accepting to participate in the trial.
✓. Patients who can understand the pain scale and can sign the informed consent.
✓. Mandibular Single rooted premolars, having single root canal: Diagnosed clinically with pulp necrosis.
✓. Positive pain on percussion denoting apical periodontitis.(20)
✓. Slight widening in the periodontal membrane space
Exclusion criteria
✕. Medically compromised patients having significant systemic disorders (ASA III or IV).
✕. If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively.
✕. Pregnant women
✕. Patients reporting bruxism, clenching, TMJ problems or traumatic occlusion
✕. Patients with two or more adjacent teeth requiring endodontic treatment.
✕
What they're measuring
1
Postoperative pain measured using numerical rating scale